TTRX Earnings Date: Nov 12, 2026 (Estimated) — Turn Therapeutics Inc.

NASDAQ · Healthcare · Biotechnology

Updated

Price $10.04
Market Cap $324.3M
P/E -36.4
52W Range $2.57 – $16.45
Next Earnings · After close (est.)

When is TTRX's next earnings date?

Turn Therapeutics Inc. (TTRX) is expected to report Q3 2026 earnings on Thursday, November 12, 2026 at 4:37 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.09.

How did TTRX do in its last earnings report?

In its most recent report on Aug 13, 2026, Turn Therapeutics Inc. posted EPS of -$0.20 versus the -$0.02 estimate, a miss of 900.0%. The stock's 1-day post-earnings move was -9.2%.

How much does TTRX stock move after earnings?

TTRX beat EPS estimates in 0 of its last 3 reported quarters. Over the last 4 reports the stock moved an average of 5.2% (up or down) in the day after earnings.

About Turn Therapeutics Inc.

Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wound care, specifically designed to help combat antibiotic resistance. Consequently, these products empower healthcare institutions to effectively manage a broad spectrum of dermatological challenges, encompassing everything from sudden injuries and persistent wounds to general skin ailments and specific dermatoses. Global Health Solutions, Inc. was established in 2015 and maintains its headquarters in Westlake Village, California.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-13-0.02-0.20-900.00%—❌ Miss-9.20%-6.83%+20.40%
2026-08-12Q2 2026-0.02-0.20-900.00%$0❌ Miss-6.45%-6.83%+20.40%
2026-05-11Q1 2026-0.02-0.03-50.00%$0❌ Miss+2.58%+26.29%+42.53%
2026-03-31Q4 2025—0.01—$0—-2.66%+9.38%+15.32%

Showing last 4 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .